Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Cadmium |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01503
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Cadmium up-regulates the expression of DME GSTO1 |
[1] |
Chloropicrin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01247
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Chloropicrin up-regulates the expression of DME GSTO1 |
[2] |
Ochratoxin A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01407
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Ochratoxin A inhibits the drug-metabolizing activity of DME GSTO1 |
[3] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene inhibits the drug-metabolizing activity of DME GSTO1 |
[4] |
Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
NCX-4040 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01394
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Environmental Pollutant |
DME Modulation |
NCX-4040 up-regulates the expression of DME GSTO1 |
[5] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Diethylhexyl phthalate up-regulates the expression of DME GSTO1 |
[6] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Particulate matter |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00919
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Particulate matter up-regulates the expression of DME GSTO1 |
[7] |
Traditional Medicine |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Jinfukang |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00760
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Traditional Medicine |
DME Modulation |
Jinfukang up-regulates the expression of DME GSTO1 |
[8] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 10 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME GSTO1 |
[9] |
Aspirin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00213
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Aspirin inhibits the expression of DME GSTO1 |
[10] |
Caffeine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00218
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Caffeine inhibits the expression of DME GSTO1 |
[11] |
Cisplatin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin up-regulates the expression of DME GSTO1 |
[8] |
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the expression of DME GSTO1 |
[12] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME GSTO1 |
[13] |
Decitabine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00168
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Decitabine induces the drug-metabolizing activity of DME GSTO1 |
[14] |
Phenytoin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00232
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Phenytoin inhibits the drug-metabolizing activity of DME GSTO1 |
[15] |
Tretinoin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Tretinoin induces the drug-metabolizing activity of DME GSTO1 |
[16] |
Valproic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid inhibits the drug-metabolizing activity of DME GSTO1 |
[17] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
AM-80 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00622
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2/3 |
DME Modulation |
AM-80 induces the drug-metabolizing activity of DME GSTO1 |
[18], [19] |
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the expression of DME GSTO1 |
[20] |
Trichloroethylene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00587
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Trichloroethylene up-regulates the expression of DME GSTO1 |
[21], [22] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Sodium arsenite |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Sodium arsenite inhibits the expression of DME GSTO1 |
[23] |
Trichostatin A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01492
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Trichostatin A up-regulates the expression of DME GSTO1 |
[24] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
ICG-001 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
ICG-001 inhibits the expression of DME GSTO1 |
[25] |
|
|
|
|
|
|